Women with COPD.

https://bit.ly/2X7Klmd.

The evolving role of tiotropium in asthma.

Tiotropium is a long-acting muscarinic antagonist (LAMA) that exerts its bronchodilatory effect by blocking endogenous acetylcholine receptors in the airways. Its safety and efficacy are well established for the treatment of COPD, and it is now being recognized for its role in improving lung function and control in asthma. This review discusses the evolving role of tiotropium delivered by the Respimat in patients across the range of asthma severities and ages, and provides an overview of safety and efficacy data.